Foyston, Gordon, & Payne Inc Becton Dickinson & CO Transaction History
Foyston, Gordon, & Payne Inc
- $427 Million
- Q2 2025
A detailed history of Foyston, Gordon, & Payne Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Foyston, Gordon, & Payne Inc holds 57,594 shares of BDX stock, worth $10.7 Million. This represents 2.33% of its overall portfolio holdings.
Number of Shares
57,594
Previous 54,082
6.49%
Holding current value
$10.7 Million
Previous $12.4 Million
19.92%
% of portfolio
2.33%
Previous 3.19%
Shares
21 transactions
Others Institutions Holding BDX
# of Institutions
1,740Shares Held
260MCall Options Held
1.82MPut Options Held
696K-
Vanguard Group Inc Valley Forge, PA32.3MShares$6.03 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.15 Billion0.12% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$3.02 Billion1.76% of portfolio
-
State Street Corp Boston, MA13.4MShares$2.5 Billion0.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.88MShares$1.66 Billion0.17% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $53.2B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...